Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Apply
PEPIDH1M & Vorasidenib
ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step